[Federal Register Volume 78, Number 95 (Thursday, May 16, 2013)]
[Pages 28860-28862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11688]



National Institutes of Health

Announcement of Requirements and Registration for: ``Data Rx: 
Prescription Drug Abuse Infographic Challenge''

    Authority: 15 U.S.C. 3719.

SUMMARY: The ``Data Rx: Prescription Drug Abuse Infographic Challenge 
Concept'' challenges the general public to create an infographic that 
presents information, rooted in the current research, concerning the 
growing trend of prescription drug abuse. The infographic should be 
designed to inform and educate the general public in interesting, 
novel, and creative ways about the dangers involved with the abuse of 
prescription drugs.

DATES: (1) Submission Period begins May 13, 2013, 12:01 a.m., EDT.
    (2) Submission Period ends June 14, 2013, 11:59 p.m., EDT.
    (3) Judging will take place between June 11-July 15, 2013.
    (4) Winners will be notified and prizes awarded July 30, 2013.

FOR FURTHER INFORMATION CONTACT: Dr. Bethany Deeds, Deputy Branch 
Chief, Epidemiology Research Branch, Division of Epidemiology, Services 
and Prevention Research, National Institute on Drug Abuse, Phone: 301-
402-1935, email [email protected].


Subject of Challenge Competition

    Prescription drug abuse is a growing drug problem for America. 
Rates of death by drug overdose have more than tripled since 1990. Most 
of these deaths are caused by prescription drugs. Infographics are 
frequently used to communicate complex information in a clear, concise 
and visually appealing manner to the public. Compared to other topical 
areas (e.g., politics, economics) the usage of infographics in health 
science is extremely limited, and infographics relevant to substance 
use and abuse rarely utilize primary data sources.
    The infographic submissions in response to ``Data Rx: Prescription 
Drug Abuse Infographic Challenge Concept'' (the ``Challenge'') are 
intended to increase awareness about the dangers of prescription drug 
abuse based on latest research.
    This Challenge is in accordance with the National Institute on Drug 
Abuse (NIDA) statutory authority, described in 42 U.S.C. 285o. The 
general purpose of NIDA is the conduct and support of biomedical and 
behavioral research, health services research, research training, and 
health information dissemination with respect to the prevention of drug 
abuse and the treatment of drug abusers. Consistent with this 
authority, one of NIDA's strategic goals is to prevent the initiation 
of drug use and the escalation to addiction in those who have already 
initiated use. Infographics that achieve the goals underlying this 
Challenge will utilize the latest research to identify the 
characteristics and patterns of prescription drug abuse and, 
accordingly, will support this strategic goal.

Entry Materials

    Applications for this Challenge will include the following 
    (1) An infographic (in .jpeg format with at least a 300 dots- per-
inch [dpi] resolution) that increases awareness and clearly outlines 
the associated dangers of prescription drug abuse.
    (2) A 1-page summary to accompany the infographic (4,000-character 
maximum). Develop a summary that explains your main points, selected 
approach and what conclusions the data visualization helps make. 
References are required and do not count towards the character limit.
    (3) Written consent to the eligibility rules upon or before 
submitting an application.
    All Entry Materials must be in English. All requested information 
must be provided for your application to be valid.
    All Entry Materials, including items 1 through 3, must be submitted 
to Challenge.gov which is an online challenge platform administered by 

[[Page 28861]]

U.S. General Services Administration (GSA) that empowers the U.S. 
Government and the public to bring the best ideas and top talent to 
bear on our nation's most pressing challenges. Access the 
www.challenge.gov Web site and search for ``Data Rx: Prescription Drug 
Abuse Infographic Challenge.''

Rules for Participating in the Challenge Competition

    To be eligible to win a prize under this Challenge, an individual 
or entity:
    (1) Shall have registered to participate in the Challenge under the 
rules promulgated by the National Institute on Drug Abuse (NIDA);
    (2) Shall have complied with all the requirements under this 
    (3) In the case of a private entity, shall be incorporated in and 
maintain a primary place of business in the United States, and in the 
case of an individual, whether participating singly or in a group, 
shall be a citizen or permanent resident of the United States;
    (4) In the case of an individual, must be at least 18 years old at 
the time of entry;
    (5) May not be a Federal entity or Federal employee acting within 
the scope of their employment;
    (6) Shall not be an HHS employee working on their applications 
during assigned duty hours;
    (7) Shall not be an employee of the National Institutes of Health 
(NIH); however, employees of other Operating Divisions within the 
Department of Health and Human Services (HHS) (e.g., Centers for 
Disease Control and Prevention (CDC), Substance Abuse and Mental 
Services Administration (SAMHSA)) are eligible to participate;
    (8) In the case of Federal grantees, may not use Federal funds to 
develop a Challenge application unless it is consistent with the 
purpose of their grant award;
    (9) In the case of Federal contractors, may not use Federal funds 
from a contract to develop a Challenge application or to fund efforts 
in support of a Challenge application.
    An individual or entity shall not be deemed ineligible because the 
individual or entity used Federal facilities or consulted with Federal 
employees during the Challenge if the facilities and employees are made 
available to all individuals and entities participating in the 
Challenge on an equitable basis.

Process for Registration and Submitting an Entry

    To register for this Challenge, participants must access the 
www.challenge.gov Web site and search for ``Data Rx: Prescription Drug 
Abuse Infographic Challenge Concept.'' A registration link for the 
challenge can be found on the landing page under this Challenge 

Amount of the Prize

    Up to three monetary prizes will be awarded: $3,000 for 1st place, 
$2,000 for 2nd place, and $1,000 for 3rd place. First, second, and 
third place winners will also have their infographic featured on 
visualizing.org, the creative community for infographic data and 
design. Depending on the number of applications, NIDA may also choose 
to post and recognize additional infographics on its Web site.

Payment of the Prize

    Prizes awarded under this Challenge will be paid by electronic 
funds transfer and may be subject to Federal income taxes. HHS will 
comply with the Internal Revenue Service withholding and reporting 
requirements, where applicable.

Basis Upon Which Winner Will Be Selected

    The judging panel will make recommendations based upon the 
following three criteria:
    1. Creativity and aesthetics of the infographic. (5 points) Like 
artwork, an infographic should be designed to capture the attention of 
the viewer and tell a story through creative use of visuals and layout. 
How original and attractive is the infographic?
    2. Clarity in articulating the prescription drug abuse problem. (5 
points) At its core, the potential value of data visualization lies in 
the ability to synthesize and convey complex data clearly and 
succinctly. How distinctly does the product illuminate the problem of 
prescription drug abuse?
    3. Success in translating multiple data sets into relevant visual 
information. (5 points) Synthesizing multiple, large datasets to 
deliver relevant information to the public in a visually compelling is 
an important feature of an infographic. The inclusion of more data sets 
does not necessarily translate to a better infographic if it does not 
effectively convey complex information. How well does the data 
visualization product accomplish this?
    The application must not use HHS's logo or official seal or the 
logo of NIDA in the application, and must not claim federal government 
    Scores from each criterion will be weighted equally for a maximum 
score of 15. All applications will be held until after the deadline is 
reached for a simultaneous judging process.
    NIDA reserves the right to disqualify and remove any application 
which is deemed, in the judging panel's discretion, inappropriate, 
offensive, defamatory, or demeaning.
    The evaluation process will begin by de-identifying the 
applications and removing those that are not responsive to this 
Challenge or not in compliance with all rules of eligibility. Judges 
will examine all applications in accordance with the judging criteria 
outlined above and meet to discuss the most meritorious entries. Final 
recommendations will be determined by a vote.

Additional Information

    Possible data sources include (but are not limited to):
     Arrestee Drug Abuse Monitoring Data (ADAM; http://www.whitehouse.gov/ondcp/arrestee-drug-abuse-monitoring-program)
     Behaviors Risk Factor Surveillance Survey (BRFSS: http://www.cdc.gov/brfss/)
     Drug Abuse Warning Network (DAWN; http://www.samhsa.gov/data/DAWN.aspx)
     Monitoring the Future (MTF; http://www.monitoringthefuture.org/)
     National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC; http://www.sgim.org/communities/research/dataset-compendium/national-epidemiologic-survey-on-alcohol-and-related-conditions-nesarc)
     National Health Interview Survey (NHIS; http://www.cdc.gov/nchs/nhis.htm)
     National Longitudinal Study of Adolescent Health (Add 
Health; http://www.cpc.unc.edu/projects/addhealth)
     National Longitudinal Surveys (NLS; http://www.bls.gov/nls/)
     National Survey on Drug Use & Health (NSDUH; http://www.samhsa.gov/data/NSDUH/2011SummNatFindDetTables/Index.aspx)
     Treatment Episode Data Set (TEDS; http://wwwdasis.samhsa.gov/webt/newmapv1.htm)
     Youth Risk Behavior Surveillance System (YRBSS; http://www.cdc.gov/HealthyYouth/yrbs/index.htm)
     National Addiction & HIV Data Archive Program (NAHDAP; 
     Health Data Community at data.gov (Health Data; http://www.healthdata.gov/)
    We also encourage combining or ``mashing up'' of multiple data 
sources. See ``Basis upon Which Winner Will Be Selected'' criteria 3.

[[Page 28862]]

Submission Rights

    Upon submission, each participant warrants that he or she is the 
sole author and owner of the work, and that the work is wholly original 
and does not infringe on any copyright or any other rights of any third 
party of which the participant is aware. Participants retain title and 
full ownership in and to their application. Participants expressly 
reserve all intellectual property rights (e.g., copyright). However, 
each participant may be asked to grant to NIDA and others acting on 
behalf of NIDA, a royalty-free non-exclusive worldwide license to use, 
copy for use, and display publicly all parts of the application for the 
purposes of the Challenge. This license includes posting or linking to 
the application on the official NIDA Web site and making it available 
for use by the public.


    By participating in this Challenge, participants agree to assume 
any and all risks and waive claims against the Federal Government and 
its related entities, except in the case of willful misconduct, for any 
injury, death, damage, or loss of property, revenue, or profits, 
whether direct, indirect, or consequential, arising from their 
participation in the Challenge, whether the injury, death, damage, or 
loss arises through negligence or otherwise.


    By participating in this Challenge, participants agree to indemnify 
the Federal Government against third party claims for damages arising 
from or related to Challenge activities.


    Based on the subject matter of the contest, the type of work that 
it will possibly require, as well as an analysis of the likelihood of 
any claims for death, bodily injury, or property damage, or loss 
potentially resulting from Challenge participation, participants are 
not required to obtain liability insurance or demonstrate financial 
responsibility in order to participate in this Challenge.

Privacy, Data Security, Ethics, and Compliance

    Participants are required to identify and address privacy and 
security issues in their proposed projects, and describe specific 
solutions for meeting them. In addition to complying with appropriate 
policies, procedures, and protections for data that ensures all privacy 
requirements and institutional policies are met, use of data should not 
allow the identification of the individual from whom the data was 
collected. Participants are responsible for compliance with all 
applicable federal, state, local, and institutional laws, regulations, 
and policy. These may include, but are not limited to, Health Insurance 
Portability and Accountability Act (HIPAA), HHS Protection of Human 
Subjects regulations, and FDA regulations. The following links are 
intended as a starting point for addressing regulatory requirements, 
but should not be interpreted as a complete list of resources on these 


Main link: http://www.hhs.gov/ocr/privacy/index.html.
Summary of the HIPAA Privacy Rule: http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/index.html.
Summary of the HIPAA Privacy Rule: http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/index.html.
Summary of the HIPAA Security Rule: http://www.hhs.gov/ocr/privacy/hipaa/understanding/srsummary.html.

Human Subjects--HHS

Office for Human Research Protections: http://www.hhs.gov/ohrp/index.html.
Protection of Human Subjects Regulations: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html.
Policy & Guidance: http://www.hhs.gov/ohrp/policy/index.html.
Institutional Review Boards & Assurances: http://www.hhs.gov/ohrp/assurances/index.html.

Human Subjects--U.S. Food and Drug Administration (FDA)

Clinical Trials: http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/default.htm.
Office of Good Clinical Practice: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OfficeofScienceandHealthCoordination/ucm2018191.

Consumer Protection--Federal Trade Commission (FTC)

Bureau of Consumer Protection: http://business.ftc.gov/privacy-and-security.

    Dated: May 6, 2013.
Nora Volkow,
Director, National Institute on Drug Abuse, National Institutes of 
[FR Doc. 2013-11688 Filed 5-15-13; 8:45 am]